Literature DB >> 34258741

Phytoconstituents as Lead Compounds for Anti-Dengue Drug Discovery.

Kamatchi Sundara Saravanan1, Selvam Arjunan2, Selvaraj Kunjiappan3, Parasuraman Pavadai4, Lakshmi M Sundar5.   

Abstract

Dengue is an arthropod-borne viral disease common in subtropical and tropical regions. The widespread use of traditional medicines in these regions for dengue fever (DF) has encouraged researchers to explore the therapeutic effect of herbs and their phytochemicals in dengue infection. Phytochemicals such as quercetin, baicalein, luteolin, oxindole alkaloids, celastrol and geraniin have shown significant inhibition of dengue virus in vitro. Many phytoconstituents have better selectivity index supporting their safety profile for future development. However, in vivo studies supporting therapeutic potency for these active phytoconstituents are limited. There is a need for studies translating anti-dengue profile of active phytoconstituents to find successful anti-dengue compounds.
© 2021. The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

Entities:  

Keywords:  Alkaloids; Dengue; Flavonoids; Phytoconstituents; Terpenoids

Year:  2021        PMID: 34258741     DOI: 10.1007/978-981-16-0267-2_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  69 in total

Review 1.  Dengue: an update on treatment options.

Authors:  Candice Y Y Chan; Eng Eong Ooi
Journal:  Future Microbiol       Date:  2015-11-23       Impact factor: 3.165

2.  Specific requirements for elements of the 5' and 3' terminal regions in flavivirus RNA synthesis and viral replication.

Authors:  Li Yu; Masako Nomaguchi; R Padmanabhan; Lewis Markoff
Journal:  Virology       Date:  2008-01-29       Impact factor: 3.616

Review 3.  Dengue in a changing climate.

Authors:  Kristie L Ebi; Joshua Nealon
Journal:  Environ Res       Date:  2016-07-29       Impact factor: 6.498

4.  Disease severity and mortality caused by dengue in a Dominican pediatric population.

Authors:  Alfredo J Mena Lora; Josefina Fernandez; Alfredo Morales; Yahaira Soto; Jesus Feris-Iglesias; Maximo O Brito
Journal:  Am J Trop Med Hyg       Date:  2013-11-11       Impact factor: 2.345

Review 5.  Pathogenesis of dengue: challenges to molecular biology.

Authors:  S B Halstead
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

6.  DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers.

Authors:  Guntur Fibriansah; Kristie D Ibarra; Thiam-Seng Ng; Scott A Smith; Joanne L Tan; Xin-Ni Lim; Justin S G Ooi; Victor A Kostyuchenko; Jiaqi Wang; Aravinda M de Silva; Eva Harris; James E Crowe; Shee-Mei Lok
Journal:  Science       Date:  2015-07-03       Impact factor: 47.728

Review 7.  Current Status of Dengue Therapeutics Research and Development.

Authors:  Jenny G H Low; Eng Eong Ooi; Subhash G Vasudevan
Journal:  J Infect Dis       Date:  2017-03-01       Impact factor: 5.226

Review 8.  Roles and Prospects of Dengue Virus Non-structural Proteins as Antiviral Targets: An Easy Digest.

Authors:  Hannah Norazharuddin; Ngit Shin Lai
Journal:  Malays J Med Sci       Date:  2018-10-30

9.  The current and future global distribution and population at risk of dengue.

Authors:  Jane P Messina; Oliver J Brady; Nick Golding; Moritz U G Kraemer; G R William Wint; Sarah E Ray; David M Pigott; Freya M Shearer; Kimberly Johnson; Lucas Earl; Laurie B Marczak; Shreya Shirude; Nicole Davis Weaver; Marius Gilbert; Raman Velayudhan; Peter Jones; Thomas Jaenisch; Thomas W Scott; Robert C Reiner; Simon I Hay
Journal:  Nat Microbiol       Date:  2019-06-10       Impact factor: 17.745

Review 10.  Dengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidate.

Authors:  Hong-Ru Chen; Yen-Chung Lai; Trai-Ming Yeh
Journal:  J Biomed Sci       Date:  2018-07-24       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.